These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22081070)

  • 21. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
    Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
    Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
    Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis.
    Yao LM; He JP; Chen HZ; Wang Y; Wang WJ; Wu R; Yu CD; Wu Q
    Carcinogenesis; 2012 Feb; 33(2):301-11. PubMed ID: 22159226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
    Lee SO; Chintharlapalli S; Liu S; Papineni S; Cho SD; Yoon K; Safe S
    Mol Cancer Res; 2009 Jul; 7(7):1169-78. PubMed ID: 19584258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation.
    Zhao BX; Chen HZ; Du XD; Luo J; He JP; Wang RH; Wang Y; Wu R; Hou RR; Hong M; Wu Q
    Mol Endocrinol; 2011 Aug; 25(8):1337-50. PubMed ID: 21659476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.
    Ye T; Peng J; Liu X; Hou S; Niu G; Li Y; Zeng H; Zhao D
    Microvasc Res; 2019 Mar; 122():22-33. PubMed ID: 30391133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malayoside, a cardenolide glycoside extracted from Antiaris toxicaria Lesch, induces apoptosis in human non-small lung cancer cells via MAPK-Nur77 signaling pathway.
    Hu QY; Zhang XK; Wang JN; Chen HX; He LP; Tang JS; Yao XS; Liu J
    Biochem Pharmacol; 2021 Aug; 190():114622. PubMed ID: 34043967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.
    Li DD; Sun T; Wu XQ; Chen SP; Deng R; Jiang S; Feng GK; Pan JX; Zhang XS; Zeng YX; Zhu XF
    PLoS One; 2012; 7(9):e45058. PubMed ID: 23024792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
    Roca H; Varsos ZS; Pienta KJ
    Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLL4 and Jagged1 are angiogenic targets of orphan nuclear receptor TR3/Nur77.
    Peng J; Zhao S; Li Y; Niu G; Chen C; Ye T; Zhao D; Zeng H
    Microvasc Res; 2019 Jul; 124():67-75. PubMed ID: 30930165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TR3 modulates platinum resistance in ovarian cancer.
    Wilson AJ; Liu AY; Roland J; Adebayo OB; Fletcher SA; Slaughter JC; Saskowski J; Crispens MA; Jones HW; James S; Fadare O; Khabele D
    Cancer Res; 2013 Aug; 73(15):4758-69. PubMed ID: 23720056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
    Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
    Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.
    Wang Y; Li P; Wang S; Hu J; Chen XA; Wu J; Fisher M; Oshaben K; Zhao N; Gu Y; Wang D; Chen G; Wang Y
    J Biol Chem; 2012 Jul; 287(31):25941-53. PubMed ID: 22605338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy.
    Zhang L; Liu W; Wang Q; Li Q; Wang H; Wang J; Teng T; Chen M; Ji A; Li Y
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
    Cho SD; Yoon K; Chintharlapalli S; Abdelrahim M; Lei P; Hamilton S; Khan S; Ramaiah SK; Safe S
    Cancer Res; 2007 Jan; 67(2):674-83. PubMed ID: 17234778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
    Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
    Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
    Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.